Translational Development... (TDACU)
Translational Development Acquisition Statistics
Share Statistics
Translational Development Acquisition has - shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | - |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | 12 |
| FTD / Avg. Volume | 0.05% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -46.63 and the forward PE ratio is null. Translational Development Acquisition's PEG ratio is -0.62.
| PE Ratio | -46.63 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 0.02 |
| P/FCF Ratio | -3.89 |
| PEG Ratio | -0.62 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Translational Development Acquisition.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.09, with a Debt / Equity ratio of 0.
| Current Ratio | 3.09 |
| Quick Ratio | 3.09 |
| Debt / Equity | 0 |
| Debt / EBITDA | 0 |
| Debt / FCF | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $- |
| Profits Per Employee | $- |
| Employee Count | undefined |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -44.69% in the last 52 weeks. The beta is 0.09, so Translational Development Acquisition's price volatility has been higher than the market average.
| Beta | 0.09 |
| 52-Week Price Change | -44.69% |
| 50-Day Moving Average | 10.15 |
| 200-Day Moving Average | null |
| Relative Strength Index (RSI) | 55.33 |
| Average Volume (20 Days) | 22.32K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -196.36K |
| Net Income | -71.01K |
| EBITDA | -196.36K |
| EBIT | n/a |
| Earnings Per Share (EPS) | -0.21 |
Balance Sheet
The company has 438.17K in cash and 0 in debt, giving a net cash position of 438.17K.
| Cash & Cash Equivalents | 438.17K |
| Total Debt | 0 |
| Net Cash | 438.17K |
| Retained Earnings | -5.6M |
| Total Assets | 175M |
| Working Capital | 439.93K |
Cash Flow
In the last 12 months, operating cash flow was -851.45K and capital expenditures 0, giving a free cash flow of -851.45K.
| Operating Cash Flow | -851.45K |
| Capital Expenditures | 0 |
| Free Cash Flow | -851.45K |
| FCF Per Share | -2.57 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TDACU does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for TDACU.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 21.26 |
| Piotroski F-Score | 3 |